Jay R. Luly Enanta Pharmaceuticals Inc (ENTA) insider trading activity

ENTA Quotes by TradingView

Jay R. Luly is President and CEO of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 858,026 shares of ENTA, which is worth approximately $10.3 Million. The most recent transaction as insider was on Sep 15, 2021, when has been sold 4,516 shares (Common Stock) at a price of $59.06 per share, resulting in proceeds of $266,715. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 858K
0.77% 3M change
7.03% 12M change
Total Value Held $10.3 Million

Jay R. Luly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2021
SELL
Open market or private sale
$266,715 $59.06 p/Share
4,516 Reduced 0.66%
676,972 Common Stock
Dec 15 2020
SELL
Payment of exercise price or tax liability
$93,587 $42.52 p/Share
2,201 Reduced 0.32%
681,488 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
-
7,500 Added 1.09%
683,689 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
-
26,500 Added 3.77%
676,189 Common Stock
JRL

Jay R. Luly

President and CEO
Watertown, MA

Track Institutional and Insider Activities on ENTA

Follow ENANTA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

News

Receive news related to ENANTA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ENTA